Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30088330HIVENSG00000103653.17protein_codingCSKNoNo1445B2R6Q4
P41240
TVIS30075534HIVENSG00000103653.17protein_codingCSKNoNo1445B2R6Q4
P41240
TVIS30038917HIVENSG00000103653.17protein_codingCSKNoNo1445B2R6Q4
P41240
TVIS20052448HPVENSG00000103653.17protein_codingCSKNoNo1445B2R6Q4
P41240
TVIS20044367HPVENSG00000103653.17protein_codingCSKNoNo1445B2R6Q4
P41240
TCGA Plot Options
Drug Information
GeneCSK
DrugBank IDDB01254
Drug NameDasatinib
Target IDBE0001356
UniProt IDP41240
Regulation Typeinhibitor
PubMed IDs18180381; 22928736
CitationsKneidinger M, Schmidt U, Rix U, Gleixner KV, Vales A, Baumgartner C, Lupinek C, Weghofer M, Bennett KL, Herrmann H, Schebesta A, Thomas WR, Vrtala S, Valenta R, Lee FY, Ellmeier W, Superti-Furga G, Valent P: The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils. Blood. 2008 Mar 15;111(6):3097-107. doi: 10.1182/blood-2007-08-104372. Epub 2008 Jan 7.@@Kwarcinski FE, Fox CC, Steffey ME, Soellner MB: Irreversible inhibitors of c-Src kinase that target a nonconserved cysteine. ACS Chem Biol. 2012 Nov 16;7(11):1910-7. doi: 10.1021/cb300337u. Epub 2012 Sep 5.
GroupsApproved; Investigational
Direct ClassificationAromatic anilides
SMILESCC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
PathwaysDasatinib Inhibition of BCR-ABL
PharmGKBPA162372878
ChEMBLCHEMBL1421